GHK-Cu — Peptide Dosing Protocols reference

patient_educationexpert_opinion · status: needs_provider_review

Details

Author: —

Citation: —

Summary (generated — provider review required)

GHK-Cu Peptide Dosing Guide: Skin, Hair & Safety (2026) Shop Protocols Stacks A–Z Index Email Updates Home Protocols GHK-Cu Peptide Dosing Guide: Skin, Hair & Safety (2026) Protocol / Research Dosing Guide GHK-Cu Peptide Dosing Guide: Skin, Hair & Safety (2026) An evidence-based GHK-Cu protocol guide covering dosing structure, injectable vs topical use, cycle length, and safety considerations for this copper peptide. By Garret Grant · Founder & Lead Researcher · Last reviewed June 2026 · Share Supplier Pick Copy code PEPPAL Copy code PEPPAL Verified Supplier Product-Specific Link Peptide Partners GHK-Cu Supply (100mg) Buy GHK-Cu Table of Contents View Supplies Quick Start Dosing Protocol & Schedule Supplies Needed Reconstitution Guide Dosage Chart Mechanism Who Should Avoid It Side Effects & Safety Timeline & Monitoring Clinical Evidence Storage & Handling Troubleshooting Regulatory Status GHK-Cu Comparisons Related Protocols Blood Tests FAQ References GHK-Cu Quick Start GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a small copper-binding peptide that occurs naturally in human plasma. Levels are roughly 200 ng/mL around age 20 and fall to about 80 ng/mL by age 60.

The original source document remains the source of truth. Generated summaries are not authoritative.

Linked assets (15) · phenotypes (0)

evidence_reference, dosing_reference, safety_reference, mechanism, monitoring_reference

Findings (114) · awaiting review (75)

dosing · pending

One vial covers about 50 daily 1 mg doses; community planning typically rounds down for priming losses.

dosing · pending

Cycle length Planning note 4-6 weeks 1 vial 4 weeks: 28 doses needed.; 6 weeks: 42 doses needed; one 50 mg vial is sufficient.

dosing · pending

8-12 weeks 2 vials 8 weeks: 56 doses needed; second vial provides margin for losses.; 12 weeks: 84 doses needed; two 50 mg vials cover the

dosing · pending

4-6 weeks 1 vial 4 weeks: 28 doses needed.; 6 weeks: 42 doses needed; one 50 mg vial is sufficient.

dosing · pending

Peptide Vials (Injectable) Math anchored to 50 mg vials at 25 mg/mL after 2.0 mL reconstitution.

dosing · pending

8-12 weeks 2 vials 8 weeks: 56 doses needed; second vial provides margin for losses.; 12 weeks: 84 doses needed; two 50 mg vials cover the cycle with headroom.

dosing · pending

Insulin Syringes (U-100) Use 0.3 mL / 30-unit syringes for clean 4-unit (1 mg) draws.

dosing · pending

Most BAC water sells in 10 mL bottles, which provides margin against waste.

dosing · pending

By Garret Grant · Founder & Lead Researcher · Last reviewed June 2026 · Share Supplier Pick Copy code PEPPAL Copy code PEPPAL Verified Supplier Product-Specific Link Peptide Partners GHK-Cu Supply (100mg) Buy GHK-Cu Table of Contents View Supplies Quick Start Dosing Protocol & Schedule Supplies Needed Reconstitution Guide Dosage Chart Mechanism Who Should Avoid It Side Effects & Safety Timeline & Monitoring Clinical Evidence Storage & Handling Troubleshooting Regulatory Status GHK-Cu Comparisons Related Protocols Blood Tests FAQ References GHK-Cu Quick Start GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a small copper-binding peptide that occurs naturally in human plasma.

dosing · pending

Most community use is split between topical creams or serums and subcutaneous injection.

dosing · pending

Routes Subcutaneous (SubQ) injection and topical formulations are the two main research-use routes.

dosing · pending

Common range Community discussions reference 1-2 mg per day SubQ or 1-3% topical formulations.

regulatory · pending

Status Not FDA-approved.

regulatory · pending

Injectable GHK-Cu was removed from FDA Category 2 on April 15, 2026.

dosing · pending

Dosing context describes common community-derived research planning, not a personal protocol.

dosing · pending

Use this page for GHK-Cu dosing, vial math, and handling.

safety · pending

It covers copper peptide biology, research, safety, and comparisons.

dosing · pending

GHK-Cu Dosing Protocol & Schedule GHK-Cu is researched through two very different routes: subcutaneous injection of a reconstituted vial and topical application of a cream, serum, or microneedling-adjacent formulation.

dosing · pending

The route changes the dose, the cycle length, and the supplies you need.

dosing · pending

GHK-Cu Protocol Formats Choose the format you are researching to see route-specific dosing notes.

dosing · pending

Common research-planning range Community discussions and protocol-style references commonly describe 1-2 mg per day SubQ for a 4-8 week cycle.

dosing · pending

Lower starting points (around 1 mg/day) are typical for new research planning, and 2 mg/day is the high end most references cite.

dosing · pending

Common Injectable Cycle Patterns Approach Conservative start Daily dose 1.0 mg Schedule 5 days on / 2 off Cycle length 4 weeks Approach Standard Daily dose 1.0-1.5 mg Schedule Daily Cycle length 4-6 weeks Approach Higher end Daily dose 1.5-2.0 mg Schedule Daily Cycle length 6-8 weeks Approach Daily dose Schedule Cycle length Conservative start 1.0 mg 5 days on / 2 off 4 weeks Standard 1.0-1.5 mg Daily 4-6 weeks Higher end 1.5-2.0 mg Daily 6-8 weeks Educational reference.

dosing · pending

Subcutaneous injections are typically rotated across the abdomen, outer thigh, and back of the upper arm.

dosing · pending

Common Topical Application Patterns Use case Facial anti-aging (community use) Concentration 1-2% Frequency Once or twice daily Cycle length 8-12 weeks Use case Scalp / hair-research interest Concentration 1-3% Frequency Daily Cycle length 12+ weeks ongoing Use case Compounded post-procedure Concentration 1-2% Frequency Per clinician guidance Cycle length Per clinician guidance Use case Concentration Frequency Cycle length Facial anti-aging (community use) 1-2% Once or twice daily 8-12 weeks Scalp / hair-research interest 1-3% Daily 12+ weeks ongoing Compounded post-procedure 1-2% Per clinician guidance Per clinician guidance Topical concentrations are typically expressed as percent weight.

dosing · pending

A 1% serum is roughly 10 mg of GHK-Cu per gram of finished formulation.

regulatory · pending

The strongest human evidence is topical, including the Leyden 2002 photoaging trial and a 2023 IRB-approved 21-woman topical NE

outcome · pending

EL gel study reporting an average 28% increase in skin collagen density at 3 months.

dosing · pending

Math is anchored to a 50 mg vial reconstituted with 2.0 mL bacteriostatic water (25 mg/mL), with one daily injection at 1 mg (0.04 mL = 4 units on a U-100 syringe).

dosing · pending

Verified Supplier Product-Specific Link GHK-Cu Supply (100mg) Copy PEPPAL code Buy GHK-Cu Verified Supplier Product-Specific Link GHK-Cu Supply Copy PEPPAL code Buy GHK-Cu Blood Test At-Home Blood Test Rythm Health At-Home Blood Test View Blood Test Injection Supplies Swabs Sterile alcohol pads.

dosing · pending

Cycle length Planning note 4-12 weeks 1 x 10 mL bottle 4 weeks: 2 mL used; bottle covers 1 vial easily.; 6 weeks: 2 mL used.; 8 weeks: 4 mL used across 2 vials; one bottle is enough.; 12 weeks: 4 mL used; second bottle is optional safety margin.

dosing · pending

4-12 weeks 1 x 10 mL bottle 4 weeks: 2 mL used; bottle covers 1 vial easily.; 6 weeks: 2 mL used.;

dosing · pending

8 weeks: 4 mL used across 2 vials; one bottle is enough.; 12 weeks: 4 mL used; second bottle is optional safety margin.

dosing · pending

Common Vial Sizes and Concentrations Vial size 50 mg BAC water 2.0 mL Concentration 25.0 mg/mL 1 mg draw (U-100) 0.04 mL = 4 units Vial size 50 mg BAC water 2.5 mL Concentration 20.0 mg/mL 1 mg draw (U-100) 0.05 mL = 5 units Vial size 100 mg BAC water 3.0 mL Concentration 33.3 mg/mL 1 mg draw (U-100) 0.03 mL = 3 units Vial size 100 mg BAC water 5.0 mL Concentration 20.0 mg/mL 1 mg draw (U-100) 0.05 mL = 5 units Vial size BAC water Concentration 1 mg draw (U-100) 50 mg 2.0 mL 25.0 mg/mL 0.04 mL = 4 units 50 mg 2.5 mL 20.0 mg/mL 0.05 mL = 5 units 100 mg 3.0 mL 33.3 mg/mL 0.03 mL = 3 units 100 mg 5.0 mL 20.0 mg/mL 0.05 mL = 5 units Pick a reconstitution volume that produces a draw you can read cleanly on a U-100 syringe.

dosing · pending

02 Prepare your supplies Lay out one BAC water vial, one syringe for reconstitution, one syringe for the dose, and at least two alcohol swabs.

dosing · pending

A 1% topical from a 100 mg vial reconstituted in 5 mL would mean roughly 0.5 mL (10 mg) blended into 1 g of finished base.

dosing · pending

GHK-Cu Dosage Chart This GHK-Cu dosage chart summarizes common injectable cycle patterns from a conservative 1.0 mg start through a higher-end 1.5-2.0 m

dosing · pending

GHK-Cu dosage chart summarizing common injectable cycle patterns, daily dose ranges, schedules, and cycle lengths for research planning.

mechanism · pending

It carries copper into cells where copper-dependent enzymes need it, and the GHK fragment itself acts as a signaling peptide that influences gene expression in fibroblasts and other tissue cells.

Processing

Processed into 24 searchable sections.